What's in Central Denmark Region's pipeline?

Central Denmark Region has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Central Denmark Region's portfolio?

Top competitors by shared drug class: Air Liquide Santé International, University of South Florida.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/central-denmark-region.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Central Denmark Region — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Central Denmark Region pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Standard Oxygen	Standard Oxygen	marketed	Medical gas		Respiratory / Critical Care

Therapeutic area mix

Respiratory / Critical Care · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Air Liquide Santé International · 1 shared drug class
University of South Florida · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Central Denmark Region:

Cite this brief

Drug Landscape (2026). Central Denmark Region — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/central-denmark-region. Accessed 2026-06-10.